Geary, S M <br/><br/>
Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Sep 2011 
 - 1309-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-011-1038-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Adjuvants, Immunologic--administration & dosage<br/>Animals<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--administration & dosage<br/>Cell Line, Tumor<br/>Combined Modality Therapy<br/>Disease Models, Animal<br/>Genetic Therapy--methods<br/>Humans<br/>Immunotherapy--methods<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Oligodeoxyribonucleotides--administration & dosage<br/>T-Lymphocytes, Regulatory--immunology<br/>Thymoma--drug therapy